Catalyst Wire Dossier Catalyst Wire Dossier

Apitegromab

SRK-015 · Scholar Rock, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Apitegromab, covering 2025-03-14 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy [Phase 2]

See pricing